Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer

NCT06478394 is registered in ClinicalTrials.gov with Qun Zhao as lead sponsor.

NCT NCT06478394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06478394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
Lead sponsor
Qun Zhao
Phase
Observational
Overall status
Unknown status
Start date
January 30, 2024
Completion date
December 31, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

1. locally advanced gastric cancer (lagc): the primary condition under investigation is locally advanced gastric cancer, which refers to stomach